VANCOUVER, British Columbia — Augurex Life Sciences Corp., a leader in autoimmune biomarker diagnostics, today announced that its scientific abstract, “Anti-14-3-3eta Autoantibodies: A Novel Diagnostic Biomarker that Discriminates Axial Spondyloarthritis from Mechanical Back Pain,” has been selected to receive the Immunology Abstract Award at the 2026 Association for Diagnostics & Laboratory Medicine (ADLM) Conference. The […]